Consolidated Condensed Statements of Cash Flows - USD ($) $ in Millions	3 Months Ended
	Apr. 03, 2026	Mar. 28, 2025
Cash flows from operating activities:
Net earnings	$ 94.3	$ 87.9
Non-cash items:
Depreciation expense	14.8	12.9
Amortization of acquisition-related intangible assets	17.1	19.6
Stock-based compensation expense	7.7	7.5
Change in deferred income taxes	4.3	(5.7)
Other non-cash items	0.4	11.0
Change in accounts receivable and long-term financing receivables, net	(7.3)	3.3
Change in other operating assets and liabilities	(84.8)	(26.1)
Net cash provided by operating activities	46.5	110.4
Cash flows from investing activities:
Payments for additions to property, plant and equipment	(21.7)	(17.7)
Cash paid for equity investments	(0.3)	0.0
Proceeds from sale of equity investments	1.0	0.0
Net cash used in investing activities	(21.0)	(17.7)
Cash flows from financing activities:
Proceeds from issuance of short-term debt	300.0	0.0
Proceeds from issuance of long-term debt	0.0	83.3
Repayment of long-term debt	(500.0)	(133.3)
Net proceeds from short-term borrowings	3.6	0.0
Payments for debt issuance costs	(0.4)	(2.3)
Payments of common stock cash dividend	(3.5)	(3.7)
Purchases of treasury stock	(70.0)	(55.0)
Proceeds from stock option exercises	2.2	1.9
Other financing activities	(13.1)	(10.6)
Net cash used in financing activities	(281.2)	(119.7)
Effect of exchange rate changes on cash and cash equivalents	(2.7)	4.2
Net change in cash and cash equivalents	(258.4)	(22.8)
Beginning balance of cash and cash equivalents	492.2	356.4
Ending balance of cash and cash equivalents	$ 233.8	$ 333.6